Similar articles

• ADTN (2-amino-6,7-dihydroxy-1,2,3,4-tetrahydronaphthalene): a prototype for possible dopaminergic false transmitters?

  Roberts PJ, Davis A. Roberts PJ, et al. Adv Biochem Psychopharmacol. 1978;19:177-91. Adv Biochem Psychopharmacol. 1978. PMID: 696460 No abstract available.
• Binding of [3H]apomorphine to striatal membranes prepared from rat brain after 6-hydroxydopamine and kainic acid lesions.

  Fujita N, Saito K, Iwatsubo K, Hirata A, Noguchi Y, Yoshida H. Fujita N, et al. Brain Res. 1980 May 26;190(2):593-6. doi: 10.1016/0006-8993(80)90305-4. Brain Res. 1980. PMID: 7370810 No abstract available.
• Binding of [3H]ADTN to rat striatal membranes.

  Templeton WW, Woodruff GN. Templeton WW, et al. Biochem Pharmacol. 1982 Apr 15;31(8):1629-32. doi: 10.1016/0006-2952(82)90391-4. Biochem Pharmacol. 1982. PMID: 6124259
• Altered characteristics of striatal [3H]ADTN binding following substantia nigra lesions.

  Hirschhorn ID, Makman MH. Hirschhorn ID, et al. Eur J Pharmacol. 1982 Sep 10;83(1-2):61-7. doi: 10.1016/0014-2999(82)90286-2. Eur J Pharmacol. 1982. PMID: 7128701
• A study on the localization of [3H]sulpiride binding sites in rat striatal membranes.

  Freedman SB, Mustafa AA, Poat JA, Senior KA, Wait CP, Woodruff GN. Freedman SB, et al. Neuropharmacology. 1981 Dec;20(12A):1151-5. doi: 10.1016/0028-3908(81)90056-3. Neuropharmacology. 1981. PMID: 6119635 No abstract available.